Starting a Skincare Brand? Here’s the Safest Way for First-Time Founders to Launch.

67% of beauty startups fail in their first year — not from bad branding, but from signing the wrong manufacturing contract before they understood what they were agreeing to. In this episode, we unpack why first-time skincare founders keep falling into the same three traps, and what a development-partner relationship looks like when it's structured around founder outcomes instead of order volume.

 This is essential listening for anyone preparing to launch a skincare or cosmetics brand in the United States, European Union, or Canadian markets — whether you're an independent founder, a brand consultant, or an executive launching a new line under an existing parent company.

In this episode: 

• Why "low MOQ" is rarely the binding constraint — and what actually is 
• The differentiation illusion: how 30 brands end up selling the same base formula under different labels 
• MoCRA, FDA registration, and the regulatory blind spots that surface only at the border 
• The structural difference between a contract manufacturer and a development partner 
• 
  
• What Glossier and Tower 28 actually did before launch — and why it wasn't luck 
• The 12 questions every founder should ask before signing anything 
• Why the indie beauty market is growing 22.3% YoY against 6.1% for conglomerates

Most of the people advising first-time founders make money when you move fast and order big. That's not a conspiracy — it's just how the economics work. The reliable counter is working with someone whose model is built around your success, not your order volume. 

Hosted by Diego Lapetina, PharmD, MSc, PhD — Co-founder and Creative Director at Atomic Pom Labs, a sensory branding and cosmetic innovation consultancy serving first-time skincare founders across the US, EU, Canada, and Brazil.

Download the full white paper companion to this episode at atomicpomlabs.com. 

#SkincareBrand #BeautyFounder #CosmeticManufacturing #MoCRA #IndieBeauty

Two Geeks at a Bench

Transcript

SPEAKER_00 0:00

She had the name, she had the mood board, she had a formula concept she'd been refining for two years, tested on friends, ready to bring to market, then she got her first manufacturer quote. The terms came back fast, 5,000 units minimum, payment upfront, no formula adjustments after sign-off. The contract was written in language that assumed she already knew what stability testing and responsible person designation meant. She didn't, and the manufacturer wasn't going to explain it. This is where most first-time skincare founders hit their first real wall. Not at the idea stage, not at branding, at the manufacturing process, where information is distributed unequally, and the people with the most of it are often paid by the decision you make, not the outcome you get. So today I want to walk you through what's actually happening on that first call, why so many smart founders get caught in it, and what the brains that survive their first year are doing differently. Let's get into it. Part 1, the first timer problem. The story I just told you isn't unusual, it's the baseline. According to a recent industry report from Made by Genie, 67% of beauty startups fail in year one. Not year three, year one. And the majority of those closures trace back to fundamental product formulation issues. Customer complaints, regulatory roadblocks, and manufacturing problems that surface after the first run is already paid for and sitting in a warehouse. Here's the part most founders miss. The problem isn't that you lack ambition, the problem is asymmetric information. The manufacturer knows what a stability test costs and why it matters. They know which preservative systems are restricted in the European Union. They know that MoCRA, the Modernization of Cosmetics Regulation Act, now requires every cosmetic product to display responsible person contact information, and that non-compliant products face removal from commerce. You probably don't know any of this yet. And if the manufacturer's revenue model is built on volume, they have no structural incentive to slow down and teach you. That asymmetry, that gap between what they know and what you're allowed to know before signing, is the foundation underneath every trap I'm about to walk you through. Keep it in mind, it's the through line. MOQ stands for minimum order quantity, the smallest run a manufacturer is willing to produce. The market has responded to founder demand, so you can now find white label suppliers offering runs as low as 50 units. Custom manufacturing typically starts at 3 to 5,000. Packaging manufacturers often require 12,000 pieces per item. So founders do what feels logical. They search for low MOQ skincare manufacturer. They find someone offering 500 units and they feel like they've solved the problem. They haven't. A low MOQ from the wrong partner is still a trap. If the formula is locked after sign-off, you can't iterate. If the manufacturer doesn't include regulatory review, you're exposed. And here's where the second layer surfaces. If they're selling the same base formula to 30 other brands with different labels on the bottle, your differentiation is cosmetic. In the most literal sense of the word, the number isn't the point. The incentive structure is. A manufacturer who makes money on volume wants you to order more and faster. A development partner whose model is built around your success wants you to get the formula right, understand your compliance obligations, and scale when the market has actually validated your product. These are structurally different relationships. And the difference shows up in what they include without you having to ask. So before you commit to anyone, ask three questions. One, who owns the formula after the first run? Two, what compliance review is included? And three, if regulations change after launch, whose responsibility is it to flag that? If the answers are vague, you have your answer. Part three. The regulatory reality. Now the third trap, and this is the one most founders underestimate. Regulatory exposure. Cosmetics compliance is neither optional nor simple. The FDA's six-month enforcement grace period for Mocrae Cosmetic Facility Registration and product listing expired on July 1st, 2024. After that date, non-registered facilities, including foreign manufacturers, became exposed to import detention and refusal of entry. That's not a hypothetical consequence. That's products sitting at a port, that's a launch date you can't hit. That's a cash flow crisis you didn't plan for. And cross the Atlantic, the rules shift again. In the European Union, the cosmetics regulation maintains a list of restricted and prohibited ingredients, updated regularly by the Scientific Committee on Consumer Safety. Essential oils, certain preservatives, and common actives that are perfectly legal in the US are restricted or banned in EU formulations. If you're planning to sell in both markets, your formula needs to be built for both from the start, not retrofitted after launch. A regulatory consultant typically costs between $2,000 and $5,000. Remediating a compliance violation after the fact costs multiples of that before you even account for unsellable inventory. So the question every founder should ask before signing anything is this Who is responsible for keeping my formula compliant as regulations change? If the answer is vague, that's a vendor who has already moved on to the next order. Alright. So if those are the traps, what does the alternative look like? The brands that get this right tend to follow a similar pattern. And I want to give you two examples that I think are worth studying. The first is Glossier. Before launching a single product, Glossier had built a community of more than 15,000 Instagram followers. And when they launched, they launched with just four products: a face mist, a priming moisturizer, a bomb, and a skin tint. The narrow lineup did two things at once. It concentrated their marketing energy on a handful of hero products. And it sidestepped the decision fatigue that bloated beauty assortments impose on customers. Not because they couldn't make more, but because a small, focused launch is a strategic asset, not a compromise. The same logic applies to Tower 28. Founded in 2019, the brand launched with a hero product built around a specific underserved need, makeup for sensitive skin. And when their beach police tinted lip and cheek balm hit Cult Beauty, the majority of their stock sold out within 30 minutes of the launch announcement. That's demand validation before scaling. That's the market telling you what to make more of instead of you guessing and praying. Now contrast that with the broader industry. Fifty billion dollars in annual waste from excess inventory. Fifty billion. The founders who avoid that number aren't lucky. They're the ones who refuse to let someone else's volume incentives drive their inventory decisions. There's a phrase I want you to hold on to. Launch, learn, scale in that order. For a regulated capital-intensive physical product, it's not a startup cliche. It's the only model that preserves your ability to respond to what the market actually tells you. And the market is responding. Indie dollar sales grew 22.3% year over year compared to just 6.1% for the major conglomerates, reaching $40 billion in annual sales. The market is rewarding differentiation. It is not rewarding speed for its own sake. Part 5. The map was always available. So let me bring this home. And here's why that distinction matters. Most of the people advising you in the early stages make money when you move fast and order big. That's not a conspiracy, it's just how the economics work. And the only reliable counter is working with someone whose model is built around your success, not your order volume. Every month spent with the wrong manufacturer is a month of sunk costs, formula lock-in, and compliance exposure you may not even know you have. The window to build something with genuine identity is early, and it narrows every time you overinvest in a direction that's hard to reverse. So if there's one thing I want you to take from today, it's this don't make your first manufacturing call alone. Come with questions, come with a concept, or come with nothing but confusion about where to start. That's actually where the most useful conversations begin. You'll find a link to book a free orientation call with our team in the show notes. And until next time, build slow, build smart, and don't let someone else's volume incentives write your story. Thanks for listening.